Profiles of Genomic Instability in High-Grade Serous Ovarian Cancer Predict Treatment Outcome
Zhigang C. Wang(Dana-Farber Cancer Institute), Matthew Schwede(Swedish Medical Center), Anna DeFazio(Peter MacCallum Cancer Centre), David D.L. Bowtell(Peter MacCallum Cancer Centre), Kathryn E. Daniels(Brigham and Women's Hospital), Kathryn Alsop(Peter MacCallum Cancer Centre), Joyce F. Liu(Dana-Farber Brigham Cancer Center), Alexander Miron(Harvard University), Ronny Drapkin(Cancer Research Center), Nicolai J. Birkbak(Brigham and Women's Hospital), Aedín C. Culhane(Harvard University), John Quackenbush(Harvard University), Ross S. Berkowitz(Brigham and Women's Hospital), Dariush Etemadmoghadam(Peter MacCallum Cancer Centre), Ruiyang Tian(Brigham and Women's Hospital), Gillian Mitchell(Peter MacCallum Cancer Centre), Helga B. Salvesen(Haukeland University Hospital), J. Dirk Iglehart(Brigham and Women's Hospital), Aquila Fatima(Dana-Farber Cancer Institute), Huiying Piao(Brigham and Women's Hospital)
Cited by 162
Related Papers
The Immune Landscape of Cancer
|Immunity|2018|6.2k
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> Mutation
|Journal of Clinical Oncology|2014|1.7k